Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 101904, 9 pages
http://dx.doi.org/10.1155/2015/101904
Research Article

Wenxin Keli versus Sotalol for Paroxysmal Atrial Fibrillation Caused by Hyperthyroidism: A Prospective, Open Label, and Randomized Study

1Department of Nuclear Medicine, Tianjin Medical University General Hospital, Anshan Road No. 154, Heping District, Tianjin 300052, China
2Department of Endocrinology, Tianjin Medical University General Hospital, Tianjin 300052, China

Received 27 June 2014; Revised 5 October 2014; Accepted 12 October 2014

Academic Editor: Myeong Soo Lee

Copyright © 2015 Zhaowei Meng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [9 citations]

The following is the list of published articles that have cited the current article.

  • Jules C. Hancox, Andrew F. James, Neil V. Marrion, Henggui Zhang, and Dierk Thomas, “Novel ion channel targets in atrial fibrillation,” Expert Opinion on Therapeutic Targets, vol. 20, no. 8, pp. 947–958, 2016. View at Publisher · View at Google Scholar
  • Yang Liu, Zhiwei Zhang, Yajuan Yang, Nixiao Zhang, Guangping Li, and Tong Liu, “The Chinese herb extract Wenxin Keli: A promising agent for the management of atrial fibrillation,” International Journal of Cardiology, vol. 203, pp. 614–615, 2016. View at Publisher · View at Google Scholar
  • Dan Hu, Hector Barajas-Martínez, Alexander Burashnikov, Brian K. Panama, Jonathan M. Cordeiro, and Charles Antzelevitch, “Mechanisms underlying atrial-selective block of sodium channels by Wenxin Keli: Experimental and theoretical analysis,” International Journal of Cardiology, 2016. View at Publisher · View at Google Scholar
  • Taiyi Wang, Ming Lu, Xi Yao, Weiwei Xie, Zheng Li, Yuling Ma, Yan Zhu, Qunqun Du, Peng Zhang, and Xiaonan Chen, “An integrated anti-arrhythmic target network of a Chinese medicine compound, Wenxin Keli, revealed by combined machine learning and molecular pathway analysis,” Molecular BioSystems, vol. 13, no. 5, pp. 1018–1030, 2017. View at Publisher · View at Google Scholar
  • David Calvo, David Filgueiras-Rama, and José Jalife, “Mechanisms and drug development in atrial fibrillation,” Pharmacological Reviews, vol. 70, no. 3, pp. 505–525, 2018. View at Publisher · View at Google Scholar
  • Oholi Tovia Brodie, Bernard Belhassen, and Yoav Michowitz, “Pharmacological therapy in Brugada syndrome,” Arrhythmia and Electrophysiology Review, vol. 7, no. 2, pp. 135–142, 2018. View at Publisher · View at Google Scholar
  • Zhuogen He, Minan Zheng, Pingchang Xie, Yuanping Wang, Xia Yan, and Dingwei Deng, “Wenxin Keli for atrial fibrillation,” Medicine (United States), vol. 97, no. 17, 2018. View at Publisher · View at Google Scholar
  • Nixiao Zhang, Gary Tse, Shristi Dahal, Yajuan Yang, Mengqi Gong, Calista Zhuo Yi Chan, Enzhao Liu, Gang Xu, Konstantinos P. Letsas, Panagiotis Korantzopoulos, Guangping Li, and Tong Liu, “Efficacy of Wenxin Keli Plus Amiodarone versus Amiodarone Monotherapy in Treating Recent-Onset Atrial Fibrillation,” Cardiology Research and Practice, vol. 2018, pp. 1–7, 2018. View at Publisher · View at Google Scholar
  • Lucie Valembois, Etienne Audureau, Andrea Takeda, Witold Jarzebowski, Joël Belmin, and Carmelo Lafuente-Lafuente, “Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation,” Cochrane Database of Systematic Reviews, 2019. View at Publisher · View at Google Scholar